Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Protalix and Pfizer sign new agreement for clinical development of Elelyso

Dec. 7, 2012

Bayer HealthCare obtains European approval for new long-term contraceptive

Dec. 5, 2012

Ryzodeg passes First Committee on Drugs of Pharmaceutical Affairs review in Japan

Dec. 4, 2012

Roche patents new glucokinase activators for diabetes

Dec. 4, 2012

Taisho and Novartis sign agreement for diabetes treatment candidate in Japan

Dec. 3, 2012

New TGR5 receptor agonists prepared by Bristol-Myers Squibb

Dec. 3, 2012

New hPASK/CK II inhibitors synthesized by Bioenergenix

Dec. 3, 2012

Shionogi & Co. presents new NPY5 receptor antagonists

Nov. 30, 2012

Kowa and Sanwa Kagaku Kenkyusho set to launch Suiny in Japan

Nov. 29, 2012

Mochida Pharmaceutical patents new GRP40 receptor agonists

Nov. 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...